4CPS-141 Use of adalimumab in patients with hidradenitis suppurativa
Author(s) -
R. Fumero,
H Casas Aguado,
Sabrina Herrera,
MC Marín Guzmán,
J Cabeza Barrera
Publication year - 2018
Publication title -
section 4: clinical pharmacy services
Language(s) - English
Resource type - Conference proceedings
DOI - 10.1136/ejhpharm-2018-eahpconf.232
Subject(s) - adalimumab , medicine , hidradenitis suppurativa , concomitant , adverse effect , retrospective cohort study , refractory (planetary science) , observational study , medical prescription , medical record , dermatology , surgery , tumor necrosis factor alpha , disease , pharmacology , physics , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom